Stakeholder institutions advise, guide, and support the efforts of TB Alliance.

The TB Alliance Stakeholders Association (SHA) is an advisory committee which provides advice and support to on activities related to the research & development of anti-tuberculosis medicines and regimens; access to new TB products, the fulfilment of TBAlliance’s AAA Mandate – that all new products are adopted, available and affordable; dissemination and sharing of relevant information globally; and to participate in fundraising and advocacy efforts.

The SHA President is elected by active SHA members and serves as a voting ex officio member of the TB Alliance Board of Directors.

Stakeholders Association President

Mitchell Warren
Executive Director
AVAC

View information about our latest Stakeholders Association meeting

Apply to join the Stakeholder's Association

Community Representative, Ksenia Shchenina
Community Representative, Roger Paul Kamugasha

Our Pipeline

TB Alliance manages the largest pipeline of new TB drugs in history.

View the portfolio